What's more, in rat chondrosarcoma (RCS) chondrocyte model, CNP counteracts fibroblast growth factor 2 (FGF2) effects (which inhibit proliferation and trigger matrix degradation) by inhibiting the Erk pathway at the level of Raf-1. The gene discussed is FGF2; the disease is chondrosarcoma.